Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:S1–s106. doi:10.1136/gutjnl-2019-318484.
Table 3
Table contains the original scoring where normal =1 (ie range 3-11) and should be normal = 0 (range 0-8). Also reference 35 in the table heading should be reference 36.
Table 8
Legend for table 8 should be: “Endoscopic activity: Remission, score 0-2; Mild, score 3-6; Moderate, score 7-15; Severe, score ≥16"
3.9.7 UNIFI
Results for the 8-weekly and 12-weekly groups for the UNIFI maintenance study are the wrong way round. The sentence "In the maintenance continuation study, 523 patients with clinical response at week eight were re-randomised to placebo, 8-weekly or 12-weekly dosing, with week 44 remission rates of 24%, 38.4% and 43.8%, respectively” should be " "In the maintenance continuation study, 523 patients with clinical response at week eight were re-randomised to placebo, 8-weekly or 12-weekly dosing, with week 44 remission rates of 24%, 43.8% and 38.4%, respectively”
5.13.2 IBD-related cancer chemoprevention with mesalazine
The sentence states a dose-dependent protective effect was noted with 5-ASA with a minimum dose of 1.2 g1169 or 2 g.1171 In fact both references support a minimum dose of 1.2 g. “or 2 g” should be removed from sentence.